UPSC Recommends Rajeev Singh Raghuvanshi as Next Drug Controller General of India
DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
Govt Panel Recommends Market Authorisation for Covovax Jab as Heterologous Booster Dose
Calcium, Vitamin D, Painkillers, Anti-Allergens: DCGI Issues Alerts on Fake Drugs in Supply Chain
Uzbekistan Syrup Deaths: BJP, Congress Lock Horns Over India's 'Pharmacy to the World' Title
Samples Not Contaminated, Meets Standards: Centre Slams WHO Over Premature Links Between Children Deaths in Gambia and India-made Syrups
Exclusive | Biocon Bribery Business: Top Officer Asks Health Ministry to 'Render Justice', Revoke Suspension
WHO Alert on Cough Syrups 'Alarming', There Are Missing Links That Need to Be Probed: Expert
Banning Cocktail Drugs, Codeine-Based Syrups -- Tasks DCGI Told to Finish as Govt Extends His Tenure
Covid Precautionary Dose Must as Protection is on Decline: Nat'l Task Force Head VK Paul
DCGI Grants Marketing Authorisation to SII's QHPV Vaccine Against Cervical Cancer
Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots
Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab
Over 8.5 Lakh Doses of Zydus’s Covid Vaccine Await Drug Regulator Nod for Market Rollout
Health Ministry Asks DCGI to Rid India of Poor-quality Medicines, Prescribes Raids on Erring Pharma Firms
Zydus Gets DCGI Nod for Drug to Treat Anaemia Associated with Chronic Kidney Disease
Indians Bought 1.2 Cr 'Controversial' anti-Covid Molnupiravir Pills for Rs 50 Cr in First Month of Launch
Molnupiravir: Best Bet Against Covid-19 or Too Much of a Gamble? India's Medical Fraternity Divided
Govt Asks Chemists to Ensure Adequate Stock of Essential Medicines As Covid-19 Cases Surge
Over 100 Cr Covishield Doses Given in India, Abroad Testimony of Its Safety, Efficacy: SII